Biopharmaceutical firm Aerpio Therapeutics Inc closes Series A funding round extension worth USD9 million.

After raising USD 18.2 million, Surefire Medical announced the completion of its Series B funding. Commercial stage medical device company, Surefire Medical Inc, develops innovative infusion systems for procedures determined as minimally invasive and direct to target intervention.

Twitter Inc soared as much as 92 percent in its first day of trading on Thursday on the New York Stock Exchange as investors snapped up shares in the popular microblogging site in a frenzy that recalled the days of the dot-com bubble.

Blumberg Capital raises USD150 million with its venture capital seed fund. In an announcement, Blumberg Capital said it had closed Blumberg Capital III.

Deutsche Bank AG, Societe Generale SA and Harvest Global Investments now have China linked ETFs available.

Ernst and Young publishes its annual report on the real estate private equity sector. According to the publication Global Market Outlook: Trends in Real Estate Private Equity, the emergence from recession and its consequent effects signals the real estate private equity sector position for growth in 2014.

USD9 million was raised in Series A funding round for ImmunGene Inc. Biotechnology company ImmunGene Inc. is focused on the development of anti-body cytokine fusion technology therapy for oncological applications.

Austin-based venture capital firm Silverton Partners would be using the USD75 million it raised for Fund IV to support the local startup scene in Texas.

Should Apple Inc's patent technology for its potential iWatch be successful, RBC capital markets analyst Amit Daryanani said revenue coming from the iWatch could add another USD9 billion to the tech giant's revenues.

Former Netflix executive Ariel Tseitlin joins Scale Venture Partners as its newest venture partner. Former Netflix Director of Cloud Solutions Ariel Tseitlin would become one of the newest partners at Scale Venture Partners.